These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 8476227

  • 1. Chemoprevention by indomethacin of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumors.
    Grubbs CJ, Juliana MM, Eto I, Casebolt T, Whitaker LM, Canfield GJ, Manczak M, Steele VE, Kelloff GJ.
    Anticancer Res; 1993; 13(1):33-6. PubMed ID: 8476227
    [Abstract] [Full Text] [Related]

  • 2. Chemoprevention of OH-BBN-induced bladder cancer in mice by oltipraz, alone and in combination with 4-HPR and DFMO.
    Moon RC, Kelloff GJ, Detrisac CJ, Steele VE, Thomas CF, Sigman CC.
    Anticancer Res; 1994; 14(1A):5-11. PubMed ID: 8166455
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Becci PJ, Thompson HJ, Grubbs CJ, Squire RA, Brown CC, Sporn MB, Moon RC.
    Cancer Res; 1978 Dec; 38(12):4463-6. PubMed ID: 719631
    [Abstract] [Full Text] [Related]

  • 4. 4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin.
    Lubet RA, Huebner K, Fong LY, Altieri DC, Steele VE, Kopelovich L, Kavanaugh C, Juliana MM, Soong SJ, Grubbs CJ.
    Carcinogenesis; 2005 Mar; 26(3):571-8. PubMed ID: 15591090
    [Abstract] [Full Text] [Related]

  • 5. N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids.
    Becci PJ, Thompson HJ, Strum JM, Brown CC, Sporn MB, Moon RC.
    Cancer Res; 1981 Mar; 41(3):927-32. PubMed ID: 7459879
    [Abstract] [Full Text] [Related]

  • 6. Dietary beta-cryptoxanthin inhibits N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
    Miyazawa K, Miyamoto S, Suzuki R, Yasui Y, Ikeda R, Kohno H, Yano M, Tanaka T, Hata K, Suzuki K.
    Oncol Rep; 2007 Feb; 17(2):297-304. PubMed ID: 17203164
    [Abstract] [Full Text] [Related]

  • 7. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
    Grubbs CJ, Lubet RA, Koki AT, Leahy KM, Masferrer JL, Steele VE, Kelloff GJ, Hill DL, Seibert K.
    Cancer Res; 2000 Oct 15; 60(20):5599-602. PubMed ID: 11059745
    [Abstract] [Full Text] [Related]

  • 8. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
    Ozaki K, Sukata T, Yamamoto S, Uwagawa S, Seki T, Kawasaki H, Yoshitake A, Wanibuchi H, Koide A, Mori Y, Fukushima S.
    Cancer Res; 1998 Sep 01; 58(17):3806-11. PubMed ID: 9731488
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effects of the aqueous extract of Magnolia officinalis on the responses of human urinary bladder cancer 5637 cells in vitro and mouse urinary bladder tumors induced by N-Butyl-N-(4-hydroxybutyl) nitrosamine in vivo.
    Lee SJ, Cho YH, Park K, Kim EJ, Kang BS, Jung KH, Kim CH, Kim WJ, Moon SK.
    Phytother Res; 2009 Jan 01; 23(1):20-7. PubMed ID: 19048611
    [Abstract] [Full Text] [Related]

  • 10. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hiasa Y, Kitahori Y, Konishi N, Shimoyama T, Miyashiro A.
    J Natl Cancer Inst; 1985 Jan 01; 74(1):235-9. PubMed ID: 3855482
    [Abstract] [Full Text] [Related]

  • 11. Comparative carcinogenicity of N-butyl-N-(3-carboxypropyl)-nitrosamine and N-butyl-N-(4-hydroxybutyl)nitrosamine for the urinary bladder of (C57BL/6 X DBA/2)F1 mice.
    Irving CC, Murphy WM, Daniel DS.
    J Natl Cancer Inst; 1984 Sep 01; 73(3):753-6. PubMed ID: 6590920
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of urinary bladder cancer by N-(ethyl)-all-trans-retinamide and N-(2-hydroxyethyl)-all-trans-retinamide in rats and mice.
    Thompson HJ, Becci PJ, Grubbs CJ, Shealy YF, Stanek EJ, Brown CC, Sporn MB, Moon RC.
    Cancer Res; 1981 Mar 01; 41(3):933-6. PubMed ID: 7459880
    [Abstract] [Full Text] [Related]

  • 13. Urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in dogs.
    Okajima E, Hiramatsu T, Hirao K, Ijuin M, Hirao Y, Babaya K, Ikuma S, Ohara S, Shiomi T, Hijioka T, Ohishi H.
    Cancer Res; 1981 May 01; 41(5):1958-66. PubMed ID: 7214364
    [Abstract] [Full Text] [Related]

  • 14. Effect of vitamin A acetate on urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
    Miyata Y, Tsuda H, Matayoshi-Miyasato K, Fukushima S, Murasaki G, Ogiso T, Ito N.
    Gan; 1978 Dec 01; 69(6):845-8. PubMed ID: 750276
    [Abstract] [Full Text] [Related]

  • 15. Effect of delay in administration of 13-cis-retinoic acid on the inhibition of urinary bladder carcinogenesis in the rat.
    Becci PJ, Thompson HJ, Grubbs CJ, Brown CC, Moon RC.
    Cancer Res; 1979 Aug 01; 39(8):3141-4. PubMed ID: 455298
    [Abstract] [Full Text] [Related]

  • 16. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Kitahori Y, Konishi N, Shimoyama T, Hiasa Y.
    Jpn J Cancer Res; 1985 Sep 01; 76(9):818-22. PubMed ID: 3932279
    [Abstract] [Full Text] [Related]

  • 17. Chemoprevention of mouse urinary bladder carcinogenesis by fermented brown rice and rice bran.
    Kuno T, Hirose Y, Yamada Y, Hata K, Qiang SH, Asano N, Oyama T, Zhi H, Iwasaki T, Kobayashi H, Mori H.
    Oncol Rep; 2006 Mar 01; 15(3):533-8. PubMed ID: 16465408
    [Abstract] [Full Text] [Related]

  • 18. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Shirai T, Tagawa Y, Fukushima S, Imaida K, Ito N.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6726-30. PubMed ID: 3677102
    [Abstract] [Full Text] [Related]

  • 19. [Effect of carboquone (esquinone) on the development of urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine].
    Okajima E, Hiramatsu T, Okamoto M, Kihoin K, Ijuin M, Hirao Y, Ohara S, Babaya K, Kubota K, Samma S, Okamura K, Kaneko Y, Horii Y, Moriya A.
    Gan To Kagaku Ryoho; 1982 May 15; 9(5):836-42. PubMed ID: 7184430
    [Abstract] [Full Text] [Related]

  • 20. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okazaki K, Yamagishi M, Son HY, Imazawa T, Furukawa F, Nakamura H, Nishikawa A, Masegi T, Hirose M.
    Nutr Cancer; 2002 May 15; 42(2):211-6. PubMed ID: 12416262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.